Traws Pharma, Inc. Other Receivables, Net, Current
Traws Pharma, Inc. (TRAW) had Other Receivables, Net, Current of $35.00 thousand as of 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Notes
us-gaap:OtherReceivablesNetCurrent · last filed 2019-08-14
- 2019-06-30: Other Receivables, Net, Current $35.00K.
- 2018-12-31: Other Receivables, Net, Current $35.00K.
- 2016-12-31: Other Receivables, Net, Current $31.00K.
- 2016-09-30: Other Receivables, Net, Current $36.00K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2019-06-30 | $35.00K 10-Q · filed 2019-08-14 |
| 2018-12-31 | $35.00K 10-Q · filed 2019-08-14 |
| 2016-12-31 | $31.00K 10-K · filed 2017-03-29 |
| 2016-09-30 | $36.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $49.00K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $147.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $120.00K 10-K · filed 2017-03-29 |
| 2015-09-30 | $26.00K 10-Q · filed 2015-11-12 |
| 2014-12-31 | $132.00K 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |